The Solute Carrier MFSD1 Decreases the Activation Status of β1 Integrin and Thus Tumor Metastasis.

导出 LinkOut

翻译打印收藏纠错

作者： Marko,Roblek ^[1] ; Julia,Bicher ^[1] ; Merel,van Gogh ^[2] ; Attila,György ^[1] ; Rita,Seeböck ^[3] ; Bozena,Szulc ^[4] ; Markus,Damme ^[5] ; Mariusz,Olczak ^[4] ; Lubor,Borsig ^[2] ; Daria E,Siekhaus ^[1]

作者单位： Institute of Science and Technology Austria, Klosterneuburg, Austria. ^[1] Institute of Physiology, University of Zurich, Zurich, Switzerland. ^[2] Institute of Clinical Pathology, University Hospital St. Polten, St. Polten, Austria. ^[3] Laboratory of Biochemistry, Faculty of Biotechnology, University of Wroclaw, Wroclaw, Poland. ^[4] Institute of Biochemistry, University of Kiel, Kiel, Germany. ^[5]

关键词 MFSD1 N-glycan endolysosomal transport integrin recycling solute carriers (SLC)transporter tumor cell metastasis tumor cell migration

DOI 10.3389/fonc.2022.777634

PMID 35211397

发布时间 2022-02-26

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Frontiers in oncology

2022年12卷

777634页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

The Solute Carrier MFSD1 Decreases the Activation Status of β1 Integrin and Thus Tumor Metastasis.

Frontiers in oncology

相似文献

Frontiers in oncology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

The Solute Carrier MFSD1 Decreases the Activation Status of β1 Integrin and Thus Tumor Metastasis.

Frontiers in oncology

相似文献

Frontiers in oncology

相关期刊

检索历史清除